JPRN-UMIN000020204
Completed
Phase 2
Phase II trial of perioperative chemotherapy for esophageal cancer - Phase II trial of perioperative chemotherapy for esophageal cancer
Conditionsesophageal cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- esophageal cancer
- Sponsor
- Kyoto university hospital
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. 2\) Active infection requiring systemic therapy. 3\) Positive HBs antigen, or positive HCV antibody. 4\) Pregnancy, possible pregnancy or breastfeeding. 5\) Psychiatric disease. 6\) Patients who need flucitosine, fenitoin or warfarin. 7\) Poorly controlled diabetes mellitus 8\) Severe pulmonary fibrosis or emphysema. 9\) Serious angina or myocaedial infarcion within 3 months 10\) Patients whom principle/sub\-investigator judged ineligible to participate in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage IB2,IIA2 orIIB uterine cervical cancer SGSG014Cervical cancer patients with clinical stage IB2, IIA, IIBJPRN-UMIN000009643Sankai Gynecology Study Group50
Completed
Not Applicable
Phase II trial of perioperative chemotherapy with cisplatin and dose dense paclitaxel in patients with stage Ib2-IIb uterine cervical cancer (SGSG013)JPRN-UMIN000006440Sankai Gynecology Study Group50
Active, not recruiting
Phase 1
Study of chemotherapy in operable patients with cancer of the stomachGastric CancerMedDRA version: 20.0Level: PTClassification code 10001150Term: Adenocarcinoma gastricSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-004500-22-ITGRUPPO ONCOLOGICO ITALIANO DI RICERCA CLINICA (GOIRC)65
Not yet recruiting
Not Applicable
A phase II trial of preoperative chemotherapy with capecitabine plus short-course radiotherapy for resectable T3 rectal cancerJPRN-UMIN000016518Meiwa Hospital60
Completed
Phase 2
Phase II Trial of Preoperative Chemotherapy and Bevacizumab in Patients With Stage IIIA Non-Squamous Non-Small Cell Lung Canceron-squamous, Non-small cell lung cancerJPRN-UMIN000004487Osaka International Cancer Institute30